Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 18 Neoplasm Metastasis 8 Esophageal Neoplasms 8 Carcinoma, Hepatocellular 7 Melanoma 6 Lung Neoplasms 6 Neoplasms 5 Breast Neoplasms 5 Stomach Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Head and Neck Neoplasms 3 Colorectal Neoplasms 3 Uterine Cervical Neoplasms 2 Small Cell Lung Carcinoma 2 Recurrence 2 Rectal Neoplasms 2 Pathologic Complete Response 2 Nasopharyngeal Carcinoma 2 Gastrointestinal Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma 2 Breast Neoplasms, Male 2 Turcot syndrome 1 Triple Negative Breast Neoplasms 1 Solid Tumor Cancer 1 Small Cell Lung Cancer Extensive Stage 1 Sarcoma 1 Radiation Injuries 1 Prostatic Neoplasms 1 Pleural Mesothelial Neoplasm 1

Interventions

Cyclophosphamide 28 Temozolomide 25 Irinotecan 21 dinutuximab 20 Topotecan 15 Magnetic Resonance Spectroscopy 13 Specimen Handling 12 Biopsy 12 naxitamab 11 Granulocyte-Macrophage Colony-Stimulating Factor 11 3-Iodobenzylguanidine 11 Vincristine 10 Etoposide 10 sargramostim 9 Melphalan 9 Isotretinoin 9 fludarabine 8 X-Rays 8 Colony-Stimulating Factors 8 Carboplatin 8 etoposide phosphate 7 Phantoms, Imaging 7 Doxorubicin 7 fludarabine phosphate 6 Stem Cell Transplantation 6 Nuclear Medicine Department, Hospital 6 Eflornithine 6 Thiotepa 5 Granulocyte Colony-Stimulating Factor 5 Filgrastim 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neuroblastoma × Immunotherapy × 1 year × Clear all

NCT06485947 2025-07-08

DBPilot

Princess Maxima Center for Pediatric Oncology

Phase 1 Recruiting

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡